Results 211 to 220 of about 4,627,535 (339)

Fertility-Sparing Management of Grade 2 Endometrioid Endometrial Adenocarcinoma Without Progesterone Receptor Expression: A Case Report. [PDF]

Case Rep Obstet Gynecol
Ortiz LFL, de Moraes RDR, Ribeiro RRE, Ribeiro CBH, Lessa ALF, Moraes BBM, Vieira HC, Bogani G.   +7 more
europepmc   +1 more source

Development of a Nomogram‐Based Clinical Estimation Model for Pathological Upstaging in Patients With Preoperative Ductal Carcinoma In Situ

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Preoperative diagnosis of ductal carcinoma in situ (DCIS) may be followed by pathological upstaging to invasive ductal carcinoma (IDC) upon surgical excision, a discrepancy that significantly impacts surgical planning and decisions regarding sentinel lymph node biopsy (SLNB).
Yu‐Hua Chen, Chung‐Liang Li, Ping‐Fu Yang, Hui‐Hua Hsiao, Fang‐Ming Chen, Sin‐Hua Moi   +5 more
wiley   +1 more source

HBP1 enhances progesterone receptor activity and IGFBP1 expression driving endometrial decidualization. [PDF]

Commun Biol
Guo Y, Tian W, Nie C, Huang J, Fan H, Chen Z, Lin Z, Qin A, Huang P.   +8 more
europepmc   +1 more source

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

Journal of Clinical Oncology, 2008
P. Nguyen, A. Taghian, M. Katz, A. Niemierko, R. A. Abi Raad, W. Boon, J. Bellon, J. Wong, Barbara L. Smith, J. Harris   +9 more
semanticscholar   +1 more source

Pretreatment Prediction of Tumor Recurrence in Breast Cancer After Neoadjuvant Systemic Therapy Using Machine Learning With Clinical and CT Radiomics Features

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study aimed to develop machine learning models for predicting tumor recurrence in breast cancer before neoadjuvant systemic therapy (NST) by integrating clinical and radiomic features derived from pretreatment computed tomography (CT).
Huei‐Yi Tsai, Jo‐Ching Wang, Wei‐Shiuan Chung, Jui‐Sheng Hsu, Shu‐Yen Lin, Ming‐Feng Hou, Ming‐Chung Chou   +6 more
wiley   +1 more source

Progesterone and selective progesterone receptor modulator regulate tumor-associated fibroblasts in uterine leiomyomas. [PDF]

Genes Dis
Szucio W, Milewska G, Szamatowicz M, Lebiedzińska W, Lupu O, Bernaczyk P, Leśniewska M, Guo P, Huhtaniemi I, Li X, Wołczyński S, Ponikwicka-Tyszko D, Rahman NA.   +12 more
europepmc   +1 more source

Epithelial progesterone receptor exhibits pleiotropic roles in uterine development and function

The FASEB Journal, 2012
H. Franco, Cory A. Rubel, M. Large, M. Wetendorf, Rodrigo Fernandez‐Valdivia, Jae-Wook Jeong, T. Spencer, Richard R. Behringer, J. Lydon, F. DeMayo   +9 more
semanticscholar   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

Mass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik, Petr Lapcik, Pavla Bouchalova, Pavel Bouchal   +3 more
wiley   +1 more source

Signaling Pathway Dissection After Progesterone Receptor Enhancement in an Immortalized Pre-Cancer Fallopian Tube Epithelial Cell Line. [PDF]

Int J Mol Sci
Chang YH, Wu KC, Ding DC.
europepmc   +1 more source

Functions of MAPR (membrane-associated progesterone receptor) family members as heme/steroid-binding proteins.

Current protein and peptide science, 2012
I. Kimura, Y. Nakayama, Morichika Konishi, Kazuya Terasawa, M. Ohta, N. Itoh, M. Fujimoto   +6 more
semanticscholar   +1 more source